Inductively Coupled Plasma Mass Spectrometry Method for Plasma and Intracellular Antimony Quantification Applied to Pharmacokinetics of Meglumine Antimoniate

References

• Burza S , CroftSL, BoelaertM. Leishmaniasis. Lancet392(10151), 951–970 (2018).
   PubMed Web of Science ®Google Scholar
• World Health Organization . Fact Sheets: Leishmaniasis (2020). https://www.who.int/news-room/fact-sheets/detail/leishmaniasis
   Google Scholar
• Centers for Disease Control and Prevention . Leishmaniasis, Epidemiology & Risk Factors (2020). https://www.cdc.gov/parasites/leishmaniasis/epi.html
   Google Scholar
• Sundar S , ChakravartyJ. An update on pharmacotherapy for leishmaniasis. Expert Opin. Pharmacol.16(2), 237–252 (2015).
   PubMed Web of Science ®Google Scholar
• Ponte-Sucre A , GamarroF, DujardinJCet al. Drug resistance and treatment failure in leishmaniasis: a 21st century challenge. PLoS Negl. Trop. Dis.11(12), e0006052 (2017).
   PubMed Web of Science ®Google Scholar
• Hefnawy A , BergM, DujardinJC, DeMuylder G. Exploiting knowledge on leishmania drug resistance to support the quest for new drugs. Trends Parasitol.33(3), 162–174 (2017).
   PubMed Web of Science ®Google Scholar
• Sundar S , SinghA, ChakravartyJ, RaiM. Efficacy and safety of miltefosine in treatment of post-kala-azar dermal leishmaniasis. ScientificWorldJournal2015, 414378 (2015).
   PubMedGoogle Scholar
• Shaw CD , CarterKC. Drug delivery: lessons to be learnt from Leishmania studies. Nanomedicine9(10), 1531–1544 (2014).
   PubMed Web of Science ®Google Scholar
• Haldar AK , SenP, RoyS. Use of antimony in the treatment of leishmaniasis: current status and future directions. Mol. Biol. Int.2011, 571242 (2011).
   PubMedGoogle Scholar
• Uliana SRB , TrinconiCT, CoelhoAC. Chemotherapy of leishmaniasis: present challenges. Parasitology145(4), 464–480 (2018).
   PubMed Web of Science ®Google Scholar
• Cruz A , RaineyPM, HerwaldtBLet al. Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate. J. Infect. Dis.195(4), 602–608 (2007).
   PubMed Web of Science ®Google Scholar
• Miekeley N , MortariSR, SchubachAO. Monitoring of total antimony and its species by ICP–MS and on-line ion chromatography in biological samples from patients treated for leishmaniasis. Anal. Bioanal. Chem.372(3), 495–502 (2002).
   PubMed Web of Science ®Google Scholar
• Zaghloul IY , RadwanMA, AlJaser MH, AlIssa R. Clinical efficacy and pharmacokinetics of antimony in cutaneous leishmaniasis patients treated with sodium stibogluconate. J. Clin. Pharmacol.50(11), 1230–1237 (2010).
   PubMed Web of Science ®Google Scholar
• Reis PG , AbreuAT, GuimaraesAG, TeixeiraMC, de SouzaJ, Silva-BarcellosNM. Development and validation of an analytical method for quantification of arsenic and antimony in liposomes using inductively coupled plasma-optical emission spectrometry. J. AOAC Int.96(4), 771–775 (2013).
   PubMed Web of Science ®Google Scholar
• PerkinElmer . Technical Note: The 30-Minute Guide to ICP–MS (2011). https://www.perkinelmer.com/CMSResources/Images/44-74849tch_icpmsthirtyminuteguide.pdf
   Google Scholar
• Korvela M , AnderssonM, PetterssonJ. Internal standards in inductively coupled plasma mass spectrometry using kinetic energy discrimination and dynamic reaction cells. J. Anal. Atom. Spectrom.33(10), 1770–1776 (2018).
   Web of Science ®Google Scholar
• Vanhaecke F , VanhoeH, DamsR, VandecasteeleC. The use of internal standards in Icp Ms. Talanta39(7), 737–742 (1992).
   PubMed Web of Science ®Google Scholar
• Zhang D , DuA, WangXet al. Pharmacokinetics and bioequivalence of two strontium ranelate formulations after single oral administration in healthy Chinese subjects. Xenobiotica49(4), 457–462 (2019).
   PubMed Web of Science ®Google Scholar
• Friedland BA , HoesleyCJ, PlagianosMet al. First-in-human trial of MIV-150 and zinc acetate coformulated in a carrageenan gel: safety, pharmacokinetics, acceptability, adherence, and pharmacodynamics. J. Acquir. Immune Defic. Syndr.73(5), 489–496 (2016).
   PubMed Web of Science ®Google Scholar
• Cashin PH , EhrssonH, WallinI, NygrenP, MahtemeH. Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis. Eur. J. Clin. Pharmacol.69(3), 533–540 (2013).
   PubMed Web of Science ®Google Scholar
• Fujisawa S , OhnoR, ShigenoKet al. Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide. Cancer Chemother. Pharmacol.59(4), 485–493 (2007).
   PubMed Web of Science ®Google Scholar
• Zhou Q , RuanZR, YuanH, JiangB, XuDH. Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations. World J. Gastroenterol.12(17), 2742–2748 (2006).
   PubMed Web of Science ®Google Scholar
• Frezard F , DemicheliC, RibeiroRR. Pentavalent antimonials: new perspectives for old drugs. Molecules14(7), 2317–2336 (2009).
   PubMed Web of Science ®Google Scholar
• Simiele M , D'AvolioA, BaiettoLet al. Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations. Antimicrob. Agents Chemother.55(6), 2976–2978 (2011).
   PubMed Web of Science ®Google Scholar
• Matusiewicz H , KrawczykM. Determination of total antimony and inorganic antimony species by hydride generation in situ trapping flame atomic absorption spectrometry: a new way to (ultra)trace speciation analysis. J. Anal. Atom. Spectrom.23(1), 43–53 (2008).
   Web of Science ®Google Scholar
• Altunay N , GurkanR. A new cloud point extraction procedure for determination of inorganic antimony species in beverages and biological samples by flame atomic absorption spectrometry. Food Chem.175, 507–515 (2015).
   PubMed Web of Science ®Google Scholar
• Chulay JD , FleckensteinL, SmithDH. Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate. Trans. R. Soc. Trop. Med. Hyg.82(1), 69–72 (1988).
   PubMed Web of Science ®Google Scholar
• Hui-Ming L . Development and validation of analytical method for determination of total urinary antimony by chelation in supercritical carbon dioxide using fluorinated chelating agents. Anal. Methods5(4), 897–903 (2013).
   Web of Science ®Google Scholar
• de Aguiar MG , GonçalvesJE, SouzaMD, de SilvaRE, SilveiraJN, CotaG. Plasma antimony determination during cutaneous leishmaniasis treatment with intralesional infiltration of meglumine antimoniate. Trop. Med. Int. Health23(10), 1110–1117 (2018).
   PubMed Web of Science ®Google Scholar
• Cardozo MC , CavalcanteDD, SilvaDLF, DosSantos WNL, BezerraMA. Multivariate optimization of a method for antimony determination by hydride generation atomic fluorescence spectrometry in hair samples of patients undergoing chemotherapy against Leishmaniasis. An. Acad. Bras. Cienc.88(3), 1179–1190 (2016).
   PubMed Web of Science ®Google Scholar
• dos Santos Ferreira C , SilveiraMartins P, DemicheliC, BrochuC, OuelletteM, FrézardF. Thiol-induced reduction of antimony(V) into antimony(III): a comparative study with trypanothione, cysteinyl-glycine, cysteine and glutathione. Biometals16(3), 441–446 (2003).
   PubMed Web of Science ®Google Scholar
• Croft SL . Leishmania and other intracellular pathogens: selectivity, drug distribution and PK-PD [BSP Autumn Symposium “Microbial protein targets: towards understanding and intervention”, 14th-16th September 2016, University of Durham UK]. Parasitology145(2), 237–247 (2018).
   PubMed Web of Science ®Google Scholar
• Rizk ML , ZouL, SavicRM, DooleyKE. Importance of drug pharmacokinetics at the site of action. Clin. Transl. Sci.10(3), 133–142 (2017).
   PubMed Web of Science ®Google Scholar
• Mookerjee Basu J , MookerjeeA, BanerjeeRet al. Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection. Antimicrob. Agents Chemother.52(3), 1080–1093 (2008).
   PubMed Web of Science ®Google Scholar
• Gomez MA , NavasA, PrietoMet al. Immuno-pharmacokinetics of meglumine antimoniate in patients with cutaneous leishmaniasis caused by Leishmania Viannia. Clin. Infect. Dis.10.1093/cid/ciaa1206 (2020).
   Google Scholar